Request for Nominations for Candidates To Serve on the National Public Health Surveillance and Biosurveillance Advisory Committee (NPHSBAC), 66620 [2012-27053]
Download as PDF
<![CDATA[
66620
Federal Register / Vol. 77, No. 215 / Tuesday, November 6, 2012 / Notices
noracoordinator@cdc.gov, telephone
(202) 245–0665.
Dated: November 1, 2012.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2012–27172 Filed 11–5–12; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
erowe on DSK2VPTVN1PROD with
Request for Nominations for
Candidates To Serve on the National
Public Health Surveillance and
Biosurveillance Advisory Committee
(NPHSBAC)
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the National Public Health
Surveillance and Biosurveillance
Advisory Committee (NPHSBAC). This
committee provides advice and
guidance to the Secretary of the
Department of Health and Human
Services and the Director of the Centers
for Disease Control and Prevention,
regarding the broad range of issues
impacting the human health component
of biosurveillance. The Committee will
ensure that the Federal Government is
meeting the goal of enabling State and
local government public health
surveillance capabilities. Specifically,
this includes recommendations related
to both traditional and innovative
information sources of human health
related data from State and local
government public health authorities
and appropriate private sector health
care entities. This also includes
recommendations to enable healthcare
and public health information exchange.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the Committee’s
objectives. Nominees will be selected
based upon expertise in the field of
public health surveillance and
biosurveillance; multi-disciplinary
expertise in public health; scientific and
technical expertise. Whenever possible,
nominees should be acknowledged
experts in their fields whose credibility
is beyond question. All nominees
should have demonstrated skills in
critical evaluation of data and
communication skills necessary to
promote efficient and effective
deliberations.
VerDate Mar<15>2010
15:06 Nov 05, 2012
Jkt 229001
Federal employees will not be
considered for membership. Members
may be invited to serve up to four-year
terms. Consideration is given to
representation from diverse geographic
areas, both genders, ethnic and minority
groups, and the disabled. Nominees
must be U.S. citizens.
The following information must be
submitted for each candidate: Name,
affiliation, address, telephone number,
and current curriculum vitae. Email
addresses are requested if available.
Nominations should be sent, in
writing, and postmarked by November
30, 2012 to: Vernellia Johnson,
Management and Program Analyst,
Public Health Surveillance and
Informatics Program Office, Centers for
Disease Control and Prevention, Office
of Surveillance, Epidemiology and
Laboratory Services, 2500 Century
Center Boulevard, Room 3017, Atlanta,
Georgia 30345 or via email to hft9@cdc.
gov. Telephone and facsimile
submissions cannot be accepted.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: October 26, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–27053 Filed 11–5–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0748]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Generic Drug User
Fee Cover Sheet; Form FDA 3794
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by December
6, 2012.
SUMMARY:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–NEW and
title ‘‘Generic Drug User Fee Cover
Sheet; Form FDA 3794.’’ Also include
the FDA docket number found in
brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT: Ila
S. Mizrachi, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
7726, Ila.Mizrachi@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
ADDRESSES:
Generic Drug User Fee Cover Sheet;
Form FDA 3794—(OMB Control
Number 0910–New)
On July 9, 2012, the Generic Drug
User Fee Act (GDUFA) (Pub. L. 112–
144, Title 111) was signed into law by
the President. GDUFA, designed to
speed the delivery of safe and effective
generic drugs to the public and reduce
costs to industry, requires that generic
drug manufacturers pay user fees to
finance critical and measurable program
enhancements. The user fees required
by GDUFA are as follows: A one-time
fee for original abbreviated new drug
applications (ANDAs) pending on
October 1, 2012, (also known as backlog
applications); fees for type II active
pharmaceutical ingredient (API) and
final dosage form (FDF) facilities; fees
for new ANDAs and prior approval
supplements (PASs); and a one-time fee
for drug master files (DMFs).
The purpose of this notice is to solicit
feedback on the collection of
information in an electronic form used
to calculate and pay generic drug user
fees. Proposed Form FDA 3794, the
Generic Drug User Fee Cover Sheet,
requests the minimum necessary
information to determine if a person has
satisfied all relevant user fee
obligations. The proposed form is
modeled on other FDA user fee cover
sheets, including Form FDA 3397, the
Prescription Drug User Fee Act Cover
Sheet. The information collected would
be used by the FDA to initiate the
administrative screening of generic drug
submissions and DMFs, support the
inspection of generic drug facilities, and
E:\FR\FM\06NON1.SGM
06NON1
]]>Agencies
[Federal Register Volume 77, Number 215 (Tuesday, November 6, 2012)]
[Notices]
[Page 66620]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-27053]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Request for Nominations for Candidates To Serve on the National
Public Health Surveillance and Biosurveillance Advisory Committee
(NPHSBAC)
The Centers for Disease Control and Prevention (CDC) is soliciting
nominations for possible membership on the National Public Health
Surveillance and Biosurveillance Advisory Committee (NPHSBAC). This
committee provides advice and guidance to the Secretary of the
Department of Health and Human Services and the Director of the Centers
for Disease Control and Prevention, regarding the broad range of issues
impacting the human health component of biosurveillance. The Committee
will ensure that the Federal Government is meeting the goal of enabling
State and local government public health surveillance capabilities.
Specifically, this includes recommendations related to both traditional
and innovative information sources of human health related data from
State and local government public health authorities and appropriate
private sector health care entities. This also includes recommendations
to enable healthcare and public health information exchange.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishments of the
Committee's objectives. Nominees will be selected based upon expertise
in the field of public health surveillance and biosurveillance; multi-
disciplinary expertise in public health; scientific and technical
expertise. Whenever possible, nominees should be acknowledged experts
in their fields whose credibility is beyond question. All nominees
should have demonstrated skills in critical evaluation of data and
communication skills necessary to promote efficient and effective
deliberations.
Federal employees will not be considered for membership. Members
may be invited to serve up to four-year terms. Consideration is given
to representation from diverse geographic areas, both genders, ethnic
and minority groups, and the disabled. Nominees must be U.S. citizens.
The following information must be submitted for each candidate:
Name, affiliation, address, telephone number, and current curriculum
vitae. Email addresses are requested if available.
Nominations should be sent, in writing, and postmarked by November
30, 2012 to: Vernellia Johnson, Management and Program Analyst, Public
Health Surveillance and Informatics Program Office, Centers for Disease
Control and Prevention, Office of Surveillance, Epidemiology and
Laboratory Services, 2500 Century Center Boulevard, Room 3017, Atlanta,
Georgia 30345 or via email to hft9@cdc.gov. Telephone and facsimile
submissions cannot be accepted.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the CDC and the Agency for Toxic Substances and Disease
Registry.
Dated: October 26, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-27053 Filed 11-5-12; 8:45 am]
BILLING CODE 4163-18-P
